Insmed Inc (NASDAQ:INSM)
| 26.29 Delayed Data As of May 14 |  +0.82 / +3.22%Today’s Change | 22.67 Today|||52-Week Range 45.44 | -21.03% Year-to-Date |
Latest INSM News | Press Releases
| Bellevue Group AG Buys ESSA Pharma Inc, Accolade Inc, Revolution Medicines Inc, Sells GW ... May 12 / GuruFocus News - Paid Partner Content | Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates May 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 25.47 |
| Today’s open | 25.53 |
| Day’s range | 25.35 - 26.55 |
| Volume | 44,923 |
| Average volume (3 months) | 1,125,692 |
| Market cap | $3.0B |
Data as of 3:59pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -0.18% |
| Earnings growth (this year) | -4.40% |
| Earnings growth (next 5 years) | +7.60% |
| Revenue growth (last year) | +20.48% |
| P/E ratio | NM |
| Price/Sales | 19.76 |
| Price/Book | 9.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TAROTaro Pharmaceutical ... | +0.24 | +0.32% |
| PTCTPTC Therapeutics Inc | -0.40 | -1.04% |
| PCRXPacira Biosciences I... | +0.64 | +1.04% |
| RETAReata Pharmaceutical... | +0.19 | +0.24% |
Data as of 4:00pm ET, 05/14/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $164.4M |
| Annual profit (last year) | -$294.1M |
| Net profit margin | -178.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
